Publication

Cost-effectiveness analysis of introducing universal childhood rotavirus vaccination in Bangladesh

Authored by:

Sarker AR, Sultana M, Mahumud RA, et al.

Full Citation:

Sarker AR, Sultana M, Mahumud RA, et al. 2018. Cost-effectiveness analysis of introducing universal childhood rotavirus vaccination in Bangladesh. Human Vaccines & Immunotherapeutics. 14(1).

View Publication

Additional key concepts from this publication:

Vaccination programs such as those for Rotavirus have shown a significant short-term return on investment.

Key Evidence: Vaccinating children against rotavirus in Bangladesh would prevent more than 50,000 outpatient visits and 40,000 hospitalizations in children under five each year, and reduce treatment costs by US$5.8 million over 2 years — nearly all (96%) from fewer hospitalizations. Since this study didn’t take herd effects into account, the actual impact would likely be greater.

Use of vaccines, including strengthening existing immunization programs, provides opportunities for significant reductions in disease burden with resultant economic benefits.